This topic contains a solution. Click here to go to the answer

Author Question: What antiplatelet agent is most widely used for secondary prevention of stroke? a. Aspirin c. ... (Read 107 times)

Capo

  • Hero Member
  • *****
  • Posts: 545
What antiplatelet agent is most widely used for secondary prevention of stroke?
 
  a. Aspirin c. Clopidogrel
  b. Ticlopidine d. Aspirin and clopidogrel

Question 2

It is important to educate patients with depression and their family members about reporting signs of increasing depression and suicidal thoughts. This is especially true during which time period?
 
  a. Before the initiation of treatment
  b. 1 to 2 weeks after the initiation of treatment
  c. When switching to a different medication
  d. 1 to 2 weeks after tapering off medications



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

catron30

  • Sr. Member
  • ****
  • Posts: 297
Answer to Question 1

A

Answer to Question 2

ANS: B




Capo

  • Member
  • Posts: 545
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


jordangronback

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Excellent

 

Did you know?

Human neurons are so small that they require a microscope in order to be seen. However, some neurons can be up to 3 feet long, such as those that extend from the spinal cord to the toes.

Did you know?

Street names for barbiturates include reds, red devils, yellow jackets, blue heavens, Christmas trees, and rainbows. They are commonly referred to as downers.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library